Company press releases and official corporate announcements.
A centralized feed of corporate press releases, earnings announcements, mergers, and official statements. Content is presented for informational purposes and may require additional analysis for market relevance.
12,957 total articles
CN, a major North American railway company, will report its Q1 2026 financial and operating results on April 29, 2026. The company's senior officers, including CEO Tracy Robinson, will discuss the results and outlook in a live conference call and webcast available to investors and the public.
Jeffs' Brands Ltd has officially changed its corporate name to Nexera Technologies Ltd, reflecting a strategic pivot toward advanced technology and homeland security solutions including AI-driven threat detection and advanced screening systems. The company's shares will begin trading under the new ticker NEXR on Nasdaq. This rebranding and strategi…
Immix Biopharma announced completion of enrollment in its pivotal NEXICART-2 Phase 2 trial for relapsed/refractory AL Amyloidosis. Topline results are expected in Q3 2026, followed by Biologics License Application (BLA) submission and planned commercial launch of their lead CAR-T therapy, NXC-201. The company also appointed a new Chief Medical Offi…
Clean Energy Technologies, Inc. (CETY) has entered a non-binding Letter of Intent with Hoppy Power Ltd. to evaluate and advance deployment of its High Temperature Ablative Pyrolysis (HTAP™) technology for waste-to-energy projects, with an initial site identified in Westlock, Alberta. The project aims to convert waste into clean energy with modular …
Clearmind Medicine announced the successful completion of treatment and follow-up for 18 participants in its ongoing FDA-approved Phase I/IIa clinical trial of CMND-100, a non-hallucinogenic MEAI-based oral drug candidate for Alcohol Use Disorder. The progress includes treatment of four additional participants at the Tel Aviv site, demonstrating op…
SUNation Energy, Inc., a Nasdaq-listed provider of sustainable solar solutions, announced the completion of its 10,000th solar system installation, surpassing 130 megawatts of total solar capacity across Long Island. This milestone highlights over two decades of commitment to advancing clean energy adoption, contributing an estimated $42 million in…
Pure Cycle Corporation announced that it will release its Q2 2026 financial results on April 8, 2026, followed by an earnings presentation on April 9, 2026. The company highlighted its three business segments: wholesale water and wastewater services, land development of master planned communities, and rental of single-family homes, all contributing…
XTEND, through JFB Construction Holdings, has received limited operational assessment approval from the U.S. Army Fuze Safety Board for its high-voltage safety and arming system designed for First-Person View (FPV) attack drones. This milestone positions XTEND as the first U.S. company to obtain such approval, underscoring its leadership in AI-powe…
Ambow Education Holding Ltd. (NYSE American: AMBO), a leader in AI-powered phygital education and collaboration solutions, announced it will host an exclusive Open House to demonstrate its patented HybriU platform during the ASU+GSV 2026 conference. The event offers hands-on experience with its immersive 3D and AI-driven platform that bridges physi…
YY Group Holding Limited has paused its At-The-Market (ATM) equity offering program after determining it has adequate liquidity to meet near-term operational needs and revenue guidance for fiscal year 2026. The company will cancel over one million allocated shares and does not plan to issue more shares under the program at this time. The move refle…
Eva Live Inc., a Nasdaq-listed AI-driven digital advertising company, has engaged law firm Anderson Kill P.C. to implement a strategy aligning with Nasdaq's new tokenization framework. This initiative aims to prepare GOAI for tokenized securities trading, enhancing liquidity, global investor access, and faster settlement cycles through blockchain t…
Turbo Energy S.A. expects to report unaudited revenues of $22.5-$23.5 million for fiscal year 2025, reflecting 130%-140% year-over-year growth. This growth highlights the company's successful transformation from a product-focused solar storage provider to an AI-driven intelligent energy integrator. Turbo Energy is expanding in commercial & industri…
Giftify, Inc., operating CardCash.com, announced a 14.2% year-over-year increase in sell-side order volume and an 18.5% rise in new seller acquisition for the period January 1 through March 15, 2026. These growth metrics reflect the expanding supply base of gift cards ahead of the spring buying season, driven by targeted digital marketing initiativ…
Scienture Holdings, Inc. reported a significant 216% revenue increase for 2025 driven by the successful launch of Arbli™, the first FDA-approved oral liquid losartan formulation. Gross margin improved dramatically to 76.8% with enhanced commercial coverage secured through multiple GPO and health plan agreements, positioning the company for continue…
Kaltura announced a strategic partnership with Descript to combine their AI-powered video and audio editing tools. The alliance aims to help enterprises, especially in regulated industries like healthcare, to efficiently scale video content production while maintaining compliance and human oversight. The partnership already secured a commercial cus…
Westwood Holdings Group celebrates the 25th anniversary of its Westwood Real Estate Income Fund, highlighting a legacy of disciplined investing, consistent income generation, and active management of publicly-traded real estate securities, including a focus on preferred securities issued by REITs. The fund continues to invest across both traditiona…
Esperion Therapeutics announced new data from the CLEAR Outcomes clinical trial demonstrating that their drug bempedoic acid (marketed as NEXLETOL and NEXLIZET) reduces the risk of ischemic stroke by 22% compared to placebo in statin-intolerant patients and provides cardiovascular benefits in patients with autoimmune or inflammatory diseases. These…
SEALSQ Corp., a developer of post-quantum cryptography and PKI hardware and software, has joined the ECHONET Consortium to provide its INeS PKI platform services, aiming to improve identity, authentication, and security of smart home and energy devices in Japan. This partnership supports ECHONET's security framework with scalable, secure device aut…
Tokyo Lifestyle Co., Ltd. (Nasdaq: TKLF) has entered a three-year strategic cooperation agreement with BrainAurora Medical Technology Limited (6681.HK) to develop an integrated platform combining BrainAurora's digital cognitive impairment therapies with Tokyo Lifestyle’s functional health products. The partnership aims to address the growing elderl…
JE Cleantech Holdings Limited announced that its subsidiary, JCS-Echigo Pte Ltd, secured approximately $12 million in new orders for precision cleaning systems from an existing customer in Q1 2026, with deliveries expected over the next year. The company plans to leverage longstanding customer relationships, expand its product portfolio, and enhanc…
Lianhe Sowell International Group Ltd., listed on Nasdaq as LHSW, has entered a $1.8 million contract with California-based HECA Group to develop an AI-driven steam car-wash robot. The innovative robot aims to significantly reduce water consumption in car washes by up to 90% compared to conventional systems and eliminate chemical foam usage. This p…
Eikon Therapeutics closed an upsized IPO in February 2026 raising $381 million, strengthening its balance sheet to advance multiple late-stage clinical programs primarily in oncology. Key trial enrollments completed in non-small cell lung cancer and progress continued for selective PARP1 inhibitors and a novel WRN helicase inhibitor. The company re…
WISeKey's subsidiary WISeSat.Space successfully launched its 21st satellite equipped with SEALSQ's post-quantum QS7001 chip into Low Earth Orbit via SpaceX's Transporter-16 rideshare mission. This launch marks a significant advancement in WISeKey's vision to deliver quantum-secure, high-speed broadband connectivity through a growing constellation o…
InflaRx N.V. reported Phase 3 clinical data for vilobelimab in pyoderma gangrenosum (PG) featured at the 2026 American Academy of Dermatology Annual Meeting. The study was terminated early for futility but showed promising trends in clinical remission and ulcer healing compared to placebo, alongside a favorable safety profile. InflaRx plans to enga…
Can-Fite BioPharma announced that its veterinary partner Vetbiolix has completed enrollment in a Phase 2 clinical trial testing Piclidenoson for osteoarthritis in dogs. Data is expected in Q3 2026. Vetbiolix has exercised its option to fully license Piclidenoson for veterinary use, with Can-Fite eligible for up to $325 million in payments subject t…
